Document is current
Any future updates will be listed below
-
Authors
Ibarra-Barrueta, Olatz https://orcid.org/0000-0003-0852-5496
Mora-Atorrasagasti, Oihana
Palacios-Zabalza, Itziar
Aguirre-Larracoechea, Urko
Legarreta, Maria Jose
González-Hernández, Nerea
-
Funding
Funding for this research was provided by:
Sociedad Española de Farmacia Hospitalaria (5200€)
- License Information
-
More Information
Article History
Received: 21 February 2024
Accepted: 26 August 2024
First Online: 1 October 2024
Declarations
:
: The study protocol was approved by the Institutional Review Board of the Basque Country in June 9th, 2011 and by the local committee at each hospital. The Spanish Agency for Medicines and Health Products (AEMPS), considered as a post-authorization study of observational prospective follow-up in October 24th, 2012. Patients’ written consent to participate was obtained for the study.
: Not applicable.
: During the preparation of this manuscript the authors do not use any AI- technology.
: The authors declare that they have no competing interest.
